5081 - 5090 of 8801 Results
Title
Year
-
OPENTitle: Neurological outcome and quality of life 3 months after COVID‐19: A prospective observational cohort studyJournal Name: European Journal of NeurologyPublisher: WileyVol: 28Issue #: 10Start Page: 3348End Page: 3359Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/ene.14803Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14803Citation Count: 169
-
OPENTitle: Transitioning to telegenetics in the COVID‐19 era: Patient satisfaction with remote genetic counseling in adult neurologyJournal Name: Journal of Genetic CounselingPublisher: WileyVol: 30Issue #: 4Start Page: 974End Page: 983Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/jgc4.1470Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jgc4.1470Citation Count: 24
-
OPENTitle: Proceedings of Reanimation 2021, the French Intensive Care Society International CongressJournal Name: Annals of Intensive CarePublisher: Springer Science and Business Media LLCVol: 11Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13613-021-00862-0Best OA location URL: https://annalsofintensivecare.springeropen.com/track/pdf/10.1186/s13613-021-00862-0Citation Count: 6
-
OPENTitle: Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III StudiesJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 35Issue #: 7Start Page: 781End Page: 794Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40263-021-00826-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40263-021-00826-9.pdfCitation Count: 15
-
OPENTitle: Cognitive subtypes in individuals with essential tremor seeking deep brain stimulationJournal Name: The Clinical NeuropsychologistPublisher: Informa UK LimitedVol: 36Issue #: 7Start Page: 1705End Page: 1727Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/13854046.2021.1882578Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8966432Citation Count: 13
-
OPENTitle: Chemical Replacement of Noggin with Dorsomorphin Homolog 1 for Cost-Effective Direct Neuronal ConversionJournal Name: Cellular ReprogrammingPublisher: Mary Ann Liebert IncVol: 24Issue #: 5Start Page: 304End Page: 313Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1089/cell.2021.0200Best OA location URL: https://doi.org/10.1089/cell.2021.0200Citation Count: 3
-
OPENTitle: Adaptive and pathological connectivity responses in Parkinson’s disease brain networksJournal Name: Cerebral CortexPublisher: Oxford University Press (OUP)Vol: 33Issue #: 4Start Page: 917End Page: 932Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/cercor/bhac110Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9930629Citation Count: 17
-
OPENTitle: Soft, biocompatible materials and skin-like electronics as wearable devices: an interview with John A. RogersJournal Name: National Science ReviewPublisher: Oxford University Press (OUP)Vol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/nsr/nwac191Best OA location URL: https://academic.oup.com/nsr/advance-article-pdf/doi/10.1093/nsr/nwac191/46578909/nwac191.pdfCitation Count: 6
-
OPENTitle: Inhibitory synaptic loss drives network changes in multiple sclerosis: An ex vivo to in silico translational studyJournal Name: Multiple Sclerosis JournalPublisher: SAGE PublicationsVol: 28Issue #: 13Start Page: 2010End Page: 2019Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/13524585221125381Best OA location URL: https://doi.org/10.1177/13524585221125381Citation Count: 22
-
OPENTitle: 15th Conference Clinical Trials Alzheimer's Disease, November 29–December 2, 2022, San Francisco, CA, USA: Posters (Clinical Trial Alzheimer's Disease)Journal Name: The Journal of Prevention of Alzheimer's DiseasePublisher: Elsevier BVVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.14283/jpad.2022.97Best OA location URL: https://doi.org/10.14283/jpad.2022.97Citation Count: 5